Libin Cardiovascular Institute, Foothills Medical Centre
Calgary, Alberta, T2N 2T9, Canada
NCT Number: NCT01698372
This study will test the effectiveness of negative pressure wound therapy (using the VAC Prevena device, KCI Canada Inc.) applied to the saphenous vein harvest site after Coronary Artery Bypass Grafting (CABG). When initiated immediately after surgery, this intervention may decrease the incidence of wound infection and non-infectious wound complications. It may decrease wound discomfort and improve mobility and functional recovery of the leg.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1
Calgary, Alberta, T2N 2T9, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This portable device is applied to initiate negative pressure therapy to a wound site.
Other names: Prevena Incision Management System, Prevena 125, PRE1001.S Prevena Incision Kit
Time frame: Baseline and 6 weeks
The ASEPSIS quantitative wound scoring method will be used to assess patients' leg wound healing after saphenous vein harvesting for coronary artery bypass surgery.
Time frame: Baseline and 6 weeks
Patients will be asked to evaluate the level of pain (using the Leg Incision Assessment Form) at the wound site after saphenous vein harvesting.
University of Calgary
Other
Negative Pressure Dressing to Decrease the Incidence of Leg Wound Complications After CABG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06496321
Arterial Occlusive Diseases, Arteriosclerosis
Montevideo, Uruguay
View Trial DetailsNCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial DetailsNCT06029517
Arterial Occlusive Diseases, Arteriosclerosis
Buffalo, New York, United States
View Trial DetailsNCT04058990
Arterial Occlusive Diseases, Arteriosclerosis
Kitakyushu, Fukuoka, Japan
View Trial Details